 |
| |
| From the History of Transfusion Medicine |
1999
-Blood community begins implementation of Nucleic Acid Amplification Testing (NAT) under the FDA’s Investigational New Drug (IND) application process. NAT employs a testing technology that directly detects the genetic materials of viruses like HCV and HIV.
|
|
|